Director/PDMR Shareholding

Summary by AI BETAClose X

Morgan Sindall Group plc has announced a notification regarding a transaction by a person closely associated with a person discharging managerial responsibilities. Rosalind Morgan, closely associated with Chief Executive John Morgan, transferred 3,004 ordinary shares of 5p from certificated form to her account held with Chase Nominees Limited. This transaction, which occurred outside a trading venue on 26 August 2026, resulted in no change to Rosalind Morgan's overall shareholding.

Disclaimer*

Morgan Sindall Group PLC
26 August 2026
 

MORGAN SINDALL GROUP PLC

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

The following notification is intended to satisfy the Company's obligations under Article 19.3 of EU Regulation No 596/2014 (the Market Abuse Regulation).

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Mrs Rosalind Morgan

2

 

Reason for the notification

a)

 

Position/status

Person closely associated with a person discharging managerial responsibilities, John Morgan, Chief Executive

b)

 

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Morgan Sindall Group plc

b)

 

LEI

2138008339ULDGZRB345

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p



Identification code

GB0008085614



b)

 

Nature of the transaction

 

 

Transfer of 3,004 shares from certificated form to Rosalind Morgan's account held with Chase Nominees Limited A/C CMBLJEQ, Account no 4292950. There is no change to Rosalind Morgan's shareholding as a result of this transaction.

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




N/A

3,004







d)

 

Aggregated information

N/A single transaction

- Aggregated volume


- Price




e)

 

Date of the transaction

 

26 August 2026

f)

 

Place of the transaction

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings